The first Cochrane evaluate on this topic (Yelland 2004B) was conducted to target entirely on prolotherapy injections, pursuing an previously Cochrane review of all injection therapies for reduced‐back pain (Nelemans 2003) through which the one therapy that confirmed considerable, sustained reductions in pain and disability at 6 months involved https://proleviate.com/use-conolidine-for-back-pain/